373
Participants
Start Date
March 1, 2020
Primary Completion Date
July 1, 2021
Study Completion Date
September 1, 2022
L-thyroxine at a dose of 7.5 µg/kg/d for THOP
Subjects diagnosed with THOP (as previously defined) and treated with L-thyroxine at a dose of 7.5 µg/kg/d are less likely to have an impaired ASQ score at 4 years of corrected age.
THOP without treatment
Subjects diagnosed with THOP (as previously defined) and who received no L-thyroxine treatment.
NoTHOP
Subjects diagnosed no-THOP (as previously defined)
CHU Grenoble, Grenoble
CHU Saint EtienneHopital, Saint-Etienne
HFME, Bron
Hospices Civils de Lyon
OTHER